Arthroventions™ is improving the quality of life for patients with joint disease by developing technologies that enable more effective joint care. Over 70 million Americans (1 in 5) have a form of joint disease. It impacts more people than cancer, there is no cure, and the longer and more active a lifestyle, we live the more likely we will experience it. At Arthroventions, we believe the synovial fluid is the key to diagnosing and treating the different types of joint disease, including Osteoarthritis and Rheumatoid Arthritis. Unlike other chronic diseases, such as cancer, there are no diagnostics assays that can differentiate between disease phenotypes or to predict drug responsiveness. This results in patients receiving ineffective treatments based on physician and payer preference. Our first product line is a Class I medical device that facilitates the aspiration/removal of synovial fluid from and the injection of therapeutics into the joint space, which it is estimated that 30% of these procedures miss the joint space. Our new approach reduces patient pain and decreases the probability of missing the joint space, thereby improving the delivery of therapeutics and patient comfort. Using our devices, physicians and providers can realize additional revenue with improved quality of care. Our products support all types of intra-articular injections, including corticosteroids, viscosupplementation, and new regenerative therapy products such as Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), and Adipose derived cells. Join us and take the first step towards more effective joint care.